Democratizing hedge fund level analysis tools for everyone
| About |
|---|
| PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk. |
| Info | Profile |
|---|---|
| Name | Phapros Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 09/30/2024 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Kimia Farma Tbk | 56.77 | 56.77 |
| Public < 5% | 32.83 | 32.83 |
| Masrizal A. Syarief | 10.39 | 10.39 |
| Classification | Latest % | Previous % |
|---|---|---|
| Institution | 56.77 | 56.77 |
| Retail | 32.83 | 32.83 |
| Individual | 10.4 | 10.4 |
| Management | 0.0 | 0.0 |
| Revenue Source | 2023 | 2022 |
|---|---|---|
| Generic Drugs Bearing | 51.9% | 47.5% |
| Ethical | 28.3% | 31.9% |
| Over The Counter | 18.1% | 18.7% |
| Toll-in | 1.8% | 2.0% |
| Others | 0.0% | 0.0% |
| Revenue Region | 2023 | 2022 |
|---|---|---|
| Indonesia | 100.0% | 100.0% |
| Others | 0.0% | 0.0% |
| Year | DPS | Yield [%] |
|---|---|---|
| 2023 | 13.4 | 2.1 |
| 2022 | 7.9 | 1.2 |
| Timeframe | Performance |
|---|---|
| 1W % | -0.7 |
| 1Mo % | -2.2 |
| 3Mo % | -14.7 |
| 1Yr % | -46.6 |
| Pivot | Points |
|---|---|
| R2 | 292 |
| R1 | 282 |
| S1 | 260 |
| S2 | 248 |
Link download Laporan Keuangan emiten
| Stock | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| PEHA | -2.47 | 230 B | 1.15 T | 763 B | -9 B | -90 B |
| KLBF | 21.78 | 58.13 T | 58.24 T | 32,628 B | 5,069 B | 3,241 B |
| SIDO | 13.45 | 17.40 T | 16.99 T | 3,919 B | 1,577 B | 1,171 B |
| TSPC | 7.93 | 11.95 T | 10.82 T | 13,655 B | 2,114 B | 1,448 B |
| SOHO | 18.53 | 8.25 T | 10.52 T | 10,058 B | 618 B | 463 B |
| KAEF | -4.88 | 2.39 T | 12.98 T | 10,486 B | -9 B | -562 B |